Want to see IRMD full AI Analyst Report?
Iradimed (IRMD) Ratios
Iradimed Ratios
IRMD's free cash flow for Q3 2026 was $6.87M. For the 2026 fiscal year, IRMD's free cash flow was decreased by $-130.00K and operating cash flow was $7.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.98 | 8.84 | 4.65 | 9.06 | 11.18 |
| Quick Ratio | 6.84 | 7.62 | 3.87 | 8.43 | 10.54 |
| Cash Ratio | 5.03 | 6.14 | 3.05 | 6.78 | 9.09 |
| Solvency Ratio | 1.67 | 1.74 | 0.87 | 1.14 | 1.00 |
| Operating Cash Flow Ratio | 2.45 | 3.01 | 0.82 | 1.17 | 1.65 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 67.05M | $ 63.74M | $ 55.27M | $ 65.65M | $ 65.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.13 | 1.29 | 1.16 | 1.15 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.16 | 0.18 | 0.20 |
| Net Debt to EBITDA | -1.73 | -2.08 | -2.29 | -3.42 | -5.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 76.75% | 76.94% | 76.50% | 77.45% | 76.65% |
| EBIT Margin | 33.84% | 33.14% | 30.56% | 29.32% | 23.48% |
| EBITDA Margin | 35.23% | 34.26% | 31.73% | 30.58% | 26.84% |
| Operating Profit Margin | 31.20% | 29.99% | 30.56% | 29.32% | 23.48% |
| Pretax Profit Margin | 33.84% | 33.14% | 33.16% | 30.36% | 23.52% |
| Net Profit Margin | 26.82% | 26.26% | 26.22% | 24.07% | 22.30% |
| Continuous Operations Profit Margin | 26.82% | 26.26% | 26.22% | 24.07% | 22.30% |
| Net Income Per EBT | 79.26% | 79.23% | 79.09% | 79.28% | 94.81% |
| EBT Per EBIT | 108.47% | 110.52% | 108.50% | 103.54% | 100.19% |
| Return on Assets (ROA) | 20.67% | 19.56% | 18.66% | 15.00% | 11.25% |
| Return on Equity (ROE) | 23.76% | 22.15% | 24.07% | 17.41% | 12.92% |
| Return on Capital Employed (ROCE) | 26.52% | 24.46% | 26.42% | 20.31% | 12.91% |
| Return on Invested Capital (ROIC) | 21.02% | 19.34% | 20.78% | 16.04% | 12.19% |
| Return on Tangible Assets | 21.33% | 20.20% | 19.18% | 15.37% | 11.41% |
| Earnings Yield | 1.82% | 2.76% | 2.87% | 3.61% | 1.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.13 | 6.94 | 5.36 | 4.02 | 8.14 |
| Payables Turnover | 10.71 | 8.91 | 8.29 | 6.68 | 12.47 |
| Inventory Turnover | 1.68 | 1.62 | 1.20 | 2.24 | 2.27 |
| Fixed Asset Turnover | 3.51 | 4.32 | 5.79 | 11.57 | 9.19 |
| Asset Turnover | 0.77 | 0.74 | 0.71 | 0.62 | 0.50 |
| Working Capital Turnover Ratio | 1.22 | 1.16 | 1.02 | 0.77 | 0.65 |
| Cash Conversion Cycle | 243.05 | 236.39 | 327.85 | 199.30 | 176.30 |
| Days of Sales Outstanding | 59.52 | 52.61 | 68.06 | 90.90 | 44.84 |
| Days of Inventory Outstanding | 217.61 | 224.76 | 303.80 | 163.03 | 160.73 |
| Days of Payables Outstanding | 34.08 | 40.98 | 44.00 | 54.63 | 29.26 |
| Operating Cycle | 277.13 | 277.37 | 371.85 | 253.93 | 205.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.96 | 2.02 | 1.07 | 0.80 | 0.91 |
| Free Cash Flow Per Share | 1.35 | 1.39 | 0.43 | 0.65 | 0.85 |
| Dividend Paid and CapEx Coverage Ratio | 1.09 | 1.18 | 0.63 | 0.70 | 15.18 |
| Capital Expenditure Coverage Ratio | 3.21 | 3.20 | 1.68 | 5.36 | 15.18 |
| Operating Cash Flow Coverage Ratio | 0.00 | 165.65 | 6.59 | 4.55 | 4.54 |
| Operating Cash Flow to Sales Ratio | 0.30 | 0.35 | 0.21 | 0.19 | 0.27 |
| Free Cash Flow Yield | 1.39% | 2.53% | 0.91% | 2.30% | 1.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 54.96 | 36.18 | 34.80 | 27.70 | 61.18 |
| Price-to-Sales (P/S) Ratio | 14.77 | 9.51 | 9.13 | 6.67 | 13.64 |
| Price-to-Book (P/B) Ratio | 13.08 | 8.03 | 8.38 | 4.82 | 7.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 72.03 | 39.55 | 109.62 | 43.51 | 54.25 |
| Price-to-Operating Cash Flow Ratio | 49.61 | 27.20 | 44.43 | 35.39 | 50.68 |
| Price-to-Earnings Growth (PEG) Ratio | 3.34 | 3.08 | 1.04 | 0.81 | 0.10 |
| Enterprise Value Multiple | 40.18 | 25.70 | 26.47 | 18.39 | 45.53 |
| Enterprise Value | 1.19B | 644.78M | 550.54M | 299.65M | 511.00M |
| EV to EBITDA | 40.18 | 25.70 | 26.47 | 18.39 | 45.53 |
| EV to Sales | 14.16 | 8.80 | 8.40 | 5.62 | 12.22 |
| EV to Free Cash Flow | 69.05 | 36.59 | 100.87 | 36.69 | 48.59 |
| EV to Operating Cash Flow | 47.56 | 25.16 | 40.89 | 29.84 | 45.39 |
| Tangible Book Value Per Share | 7.17 | 6.61 | 5.47 | 5.70 | 5.76 |
| Shareholders’ Equity Per Share | 7.44 | 6.85 | 5.67 | 5.86 | 5.85 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.21 | 0.21 | 0.21 | 0.05 |
| Revenue Per Share | 6.59 | 5.78 | 5.20 | 4.24 | 3.39 |
| Net Income Per Share | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 |
| Tax Burden | 0.79 | 0.79 | 0.79 | 0.79 | 0.95 |
| Interest Burden | 1.00 | 1.00 | 1.08 | 1.04 | 1.00 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 |
| SG&A to Revenue | 0.42 | 0.43 | 0.23 | 0.20 | 0.23 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Income Quality | 1.11 | 1.33 | 0.78 | 0.78 | 1.21 |
Currency in USD